Sagent Pharmaceuticals, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011
Cash flows from operating activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation
Amortization
Depreciation and amortization
Stock-based compensation
Equity in net income of joint ventures
Dividends from unconsolidated joint ventures
Gain on previously held equity interest
Change in fair value of preferred stock warrants
Deferred income taxes, net
Impairment charge
Other

Changes in operating assets and liabilities, net of effect of acquisition:
Accounts receivable
Inventories, net
Prepaid expenses and other current assets
Due from related party
Accounts payable and other accrued liabilities
Net cash provided by (used in) operating activities
Net cash provided by (used in) operating activities
Capital expenditures
Cash flows from investing activities
Capital expenditures
Acquisition of business, net of cash acquired
Return of principal balance of restricted cash
Investments in unconsolidated joint ventures
Return of capital from unconsolidated joint venture
Purchases of investments
Sale of investments
Purchase of product rights
Government grants received
Other
Net cash (used in) provided by investing activities

Cash flows from financing activities
Increase (reduction) in short-term borrowings
Proceeds from issuance of long-term debt
Repayment of long-term debt
Effect of exchange rate movements in cash
Payment of deferred financing costs
Excess tax benefits on stock option exercises
Net cash (used in) provided by financing activities

Effect of exchange rate movements in cash
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, at beginning of period
Cash and cash equivalents, at end of period
Supplemental disclosure of cash flow information
Acquisition of property, plant and equipment in accounts payable
Cash paid for interest
Cash paid for taxes

Comments